Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $8.82 Million - $11.2 Million
80,000 New
80,000 $9.07 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $25.8 Million - $41.4 Million
300,000 New
300,000 $28 Million
Q1 2023

May 11, 2023

BUY
$104.0 - $122.92 $10.4 Million - $12.3 Million
100,000 New
100,000 $11.6 Million
Q4 2019

Feb 12, 2020

SELL
$36.62 - $57.29 $1.83 Million - $2.86 Million
-50,000 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$35.53 - $43.8 $1.78 Million - $2.19 Million
50,000 New
50,000 $7.46 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ws Management Lllp Portfolio

Follow Ws Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Ws Management Lllp with notifications on news.